Insulin Glargine in Continuous Enteric Tube Feeding

Insulin glargine placental transfer Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study Short Title: Insulin glargine placental transfer

1 Division of Clinical Pharmacology and Toxicology, the Hospital for Sick Children, Toronto, Ontario, Canada, 2 Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada, 3 Division of Endocrinology, Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, and 4 Department of Laboratory Medicine and Pathobiology, University of T...

Comparing Effects of Continuous Insulin Infusion with or without Subcutaneous Glargine Insulin on Glycemic Control in Diabetic Patients Undergoing Coronary Artery Bypass Graft (CABG)

OBJECTIVE: Hyperglycemia is associated with increased morbidity and mortality in diabetic patients following coronary artery bypass grafting. Tight glycemic control in perioperative period can reduce these events. The goal of this study was to determine whether combination of continuous infusion and subcutaneous glargine as a basal insulin could improve glycemic control. MATERIAL AND METHODS:...

Abasria, INN-insulin glargine

Insulin Glargine Safety in Pregnancy

OBJECTIVE Insulin glargine (Lantus) is an extended-action insulin analog with greater stability and duration of action than regular human insulin. The long duration of action and decreased incidence of hypoglycemia provide potential advantages for its use in pregnancy. However, the placental pharmacokinetics of insulin glargine have not been studied. Therefore, the objective of this study was t...

Insulin glargine: a long acting insulin analog.

The main goal of treatment of diabetes mellitus (DM) is to maintain long term near normoglycemia. Insulin therapy plays a pivotal role in the management of DM. Most insulin preparations and insulin delivery systems, do not mimic the physiological insulin secretion in the body, leading to impaired metabolic control and increased hypoglycemic attacks. Insulin glargine is newer, long acting insuli...